Third-Trimester HIV Viremia Treated With Long-Acting Cabotegravir and Rilpivirine: A Case Report
We report the first case to quantitatively demonstrate a rapid and substantial viral load reduction using long-acting cabotegravir and rilpivirine in the third trimester of pregnancy. This case underscores the challenges some pregnant individuals face with daily oral antiretroviral therapy and the potential role of long-acting injectables in select scenarios.
Authors
- Jennifer T. Pham (ORCID: https://orcid.org/0000-0002-3791-2965)
- Noora Kazanji
- Catherine E. Ford (ORCID: https://orcid.org/0000-0001-8646-2078)
- Blake Max (ORCID: https://orcid.org/0000-0002-2388-8677)
- Rodrigo M Burgos (ORCID: https://orcid.org/0009-0006-4101-4777)
Institutions
- University of Illinois Chicago (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1093/ofid/ofaf604
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00